{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:59:56Z","timestamp":1788325196964,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:00:00Z","timestamp":1759622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:00:00Z","timestamp":1759622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12149-025-02106-8","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T12:46:21Z","timestamp":1759668381000},"page":"73-86","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Subcutaneous\/cutaneous uptake in the cancer-affected breast on 18F-FDG PET\/CT: association with post-surgical prognosis in breast cancer patients"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0136-800X","authenticated-orcid":false,"given":"Yurika","family":"Kitano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0793-9136","authenticated-orcid":false,"given":"Kanae K.","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9781-7321","authenticated-orcid":false,"given":"Tomomi W.","family":"Nobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6523-7509","authenticated-orcid":false,"given":"Takayoshi","family":"Ishimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4950-6654","authenticated-orcid":false,"given":"Ryusuke","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6690-7460","authenticated-orcid":false,"given":"Sho","family":"Koyasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6212-3351","authenticated-orcid":false,"given":"Masako","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1488-9958","authenticated-orcid":false,"given":"Masakazu","family":"Toi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5783-8048","authenticated-orcid":false,"given":"Yuji","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,5]]},"reference":[{"key":"2106_CR1","doi-asserted-by":"publisher","first-page":"108773","DOI":"10.1016\/j.ejrad.2019.108773","volume":"123","author":"W Murakami","year":"2020","unstructured":"Murakami W, Tozaki M, Sasaki M, et al. Correlation between 18F-FDG uptake on PET\/MRI and the level of tumor-infiltrating lymphocytes (TILs) in triple-negative and HER2-positive breast cancer. Eur J Radiol. 2020;123:108773.","journal-title":"Eur J Radiol"},{"key":"2106_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejrad.2018.11.031","volume":"110","author":"E Kim","year":"2019","unstructured":"Kim E, Mema E, Axelrod D, et al. Preliminary analysis: background parenchymal 18F-FDG uptake in breast cancer patients appears to correlate with background parenchymal enhancement and to vary by distance from the index cancer. Eur J Radiol. 2019;110:163\u20138.","journal-title":"Eur J Radiol"},{"key":"2106_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13550-020-00660-y","volume":"10","author":"JW Lee","year":"2020","unstructured":"Lee JW, Kim SY, Han SW, et al. 18F-FDG uptake of bone marrow on PET\/CT for predicting distant recurrence in breast cancer patients after surgical resection. EJNMMI Res. 2020;10:72.","journal-title":"EJNMMI Res"},{"key":"2106_CR4","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.1002\/cncr.24534","volume":"115","author":"JL Alberini","year":"2009","unstructured":"Alberini JL, Lerebours F, Wartski M, et al. 18F-fluorodeoxyglucose positron emission tomography\/computed tomography (FDG-PET\/CT) imaging in the staging and prognosis of inflammatory breast cancer. Cancer. 2009;115:5038\u201347.","journal-title":"Cancer"},{"key":"2106_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2967\/jnmt.114.148494","volume":"43","author":"Z Al-Faham","year":"2015","unstructured":"Al-Faham Z, Al-Katib S, Jaiyesimi I, Bhavnagri S. Evaluation of a case of inflammatory breast cancer with 18F-FDG PET\/CT. J Nucl Med Technol. 2015;43:289\u201391.","journal-title":"J Nucl Med Technol"},{"key":"2106_CR6","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1007\/s00259-013-2405-z","volume":"40","author":"L Champion","year":"2013","unstructured":"Champion L, Lerebours F, Cherel P, et al. 18F-FDG PET\/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancer. Eur J Nucl Med Mol Imaging. 2013;40:1206\u201313.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2106_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12282-014-0572-9","volume":"22","author":"T Uematsu","year":"2015","unstructured":"Uematsu T. Focal breast edema associated with malignancy on T2-weighted images of breast MRI: peritumoral edema, prepectoral edema, and subcutaneous edema. Breast Cancer. 2015;22:66\u201370.","journal-title":"Breast Cancer"},{"key":"2106_CR8","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s12282-013-0440-z","volume":"21","author":"T Uematsu","year":"2014","unstructured":"Uematsu T, Kasami M, Watanabe J. Is evaluation of the presence of prepectoral edema on T2-weighted with fat-suppression 3T breast MRI a simple and readily available noninvasive technique for estimation of prognosis in patients with breast cancer? Breast Cancer. 2014;21:684\u201392.","journal-title":"Breast Cancer"},{"issue":"1","key":"2106_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12282-012-0425-3","volume":"21","author":"T Uematsu","year":"2014","unstructured":"Uematsu T, Kasami M, Watanabe J. Can T2-weighted 3-T breast MRI predict clinically occult inflammatory breast cancer before pathological examination? A single-center experience. Breast Cancer. 2014;21(1):115\u201321.","journal-title":"Breast Cancer"},{"key":"2106_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1148\/radiol.2021202604","volume":"299","author":"TL Harada","year":"2021","unstructured":"Harada TL, Uematsu T, Nakashima K, et al. Evaluation of breast edema findings at T2-weighted breast MRI is useful for diagnosing occult inflammatory breast cancer and can predict prognosis after neoadjuvant chemotherapy. Radiology. 2021;299:53\u201362.","journal-title":"Radiology"},{"key":"2106_CR11","doi-asserted-by":"publisher","first-page":"8213","DOI":"10.1007\/s00330-022-08896-z","volume":"32","author":"ZY Xu","year":"2022","unstructured":"Xu ZY, Ding YY, Zhao K, et al. MRI characteristics of breast edema for assessing axillary lymph node burden in early-stage breast cancer: a retrospective bicentric study. Eur Radiol. 2022;32:8213\u201325.","journal-title":"Eur Radiol"},{"key":"2106_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13244-023-01424-7","volume":"14","author":"Y Chen","year":"2023","unstructured":"Chen Y, Wang L, Luo R, Liu H, Zhang Y, Wang D. Focal breast edema and breast edema score on T2-weighted images provides valuable biological information for invasive breast cancer. Insights Imaging. 2023;14:73.","journal-title":"Insights Imaging"},{"key":"2106_CR13","first-page":"1282","volume":"20","author":"D Tural","year":"2015","unstructured":"Tural D, Salim DK, Mutlu H, et al. Is there any relation between PET-CT SUVmax value and prognostic factors in locally advanced breast cancer? J BUON. 2015;20:1282\u20136.","journal-title":"J BUON"},{"key":"2106_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11307-018-1181-3","volume":"21","author":"K Paydary","year":"2019","unstructured":"Paydary K, Seraj SM, Zadeh MZ, et al. The evolving role of FDG-PET\/CT in the diagnosis, staging, and treatment of breast cancer. Mol Imaging Biol. 2019;21:1\u201310.","journal-title":"Mol Imaging Biol"},{"issue":"11","key":"2106_CR15","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s00259-010-1529-7","volume":"37","author":"M Nakajo","year":"2010","unstructured":"Nakajo M, Kajiya Y, Kaneko T, Kaneko Y, Takasaki T, Tani A, et al. FDG PET\/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion. Eur J Nucl Med Mol Imaging. 2010;37(11):2011\u201320.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2106_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.breast.2016.08.003","volume":"30","author":"T Higuchi","year":"2016","unstructured":"Higuchi T, Nishimukai A, Ozawa H, Fujimoto Y, Yanai A, Miyagawa Y, et al. Prognostic significance of preoperative 18F-FDG PET\/CT for breast cancer subtypes. Breast. 2016;30:5\u201312.","journal-title":"Breast"},{"issue":"2","key":"2106_CR17","doi-asserted-by":"publisher","first-page":"508","DOI":"10.4143\/crt.2015.172","volume":"48","author":"J Chang","year":"2016","unstructured":"Chang J, Lee J, Kim H, Kim K, Yun M, Kim S, et al. 18F-FDG PET may help to identify a subgroup of patients with T1\u2013T2 breast cancer and 1\u20133 positive lymph nodes who are at a high risk of recurrence after mastectomy. Cancer Res Treat. 2016;48(2):508\u201317.","journal-title":"Cancer Res Treat"},{"issue":"1","key":"2106_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12149-017-1217-9","volume":"32","author":"K Kitajima","year":"2018","unstructured":"Kitajima K, Miyoshi Y, Yamano T, Odawara S, Higuchi T, Yamakado K. Prognostic value of FDG-PET and DWI in breast cancer. Ann Nucl Med. 2018;32(1):44\u201353.","journal-title":"Ann Nucl Med"},{"key":"2106_CR19","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168:670\u201391.","journal-title":"Cell"},{"key":"2106_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41416-020-01161-4","volume":"124","author":"AI Riggio","year":"2021","unstructured":"Riggio AI, Varley KE, Welm AL. The lingering mysteries of metastatic recurrence in breast cancer. Br J Cancer. 2021;124:13\u201326.","journal-title":"Br J Cancer"},{"key":"2106_CR21","doi-asserted-by":"publisher","first-page":"R133","DOI":"10.1186\/bcr3333","volume":"14","author":"B Franken","year":"2012","unstructured":"Franken B, de Groot MR, Mastboom WJB, et al. Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer. Breast Cancer Res. 2012;14:R133.","journal-title":"Breast Cancer Res"},{"key":"2106_CR22","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.7150\/thno.82700","volume":"13","author":"YQ Li","year":"2023","unstructured":"Li YQ, Li M, Su KT, Zong SW, Zhang HY, Xiong LX. Pre-metastatic niche: from revealing the molecular and cellular mechanisms to the clinical applications in breast cancer metastasis. Theranostics. 2023;13:2301\u201318.","journal-title":"Theranostics"},{"key":"2106_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s43556-020-00022-z","volume":"2","author":"H Wang","year":"2021","unstructured":"Wang H, Pan JJ, Barsky L, et al. Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways. Mol Biomed. 2021;2:3.","journal-title":"Mol Biomed"},{"key":"2106_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/diagnostics12010004","volume":"12","author":"JM Chen","year":"2021","unstructured":"Chen JM, Luo B, Ma R, Luo XX, Chen YS, Li Y. Lymphatic endothelial markers and tumor lymphangiogenesis assessment in human breast cancer. Diagnostics (Basel). 2021;12:4.","journal-title":"Diagnostics (Basel)"},{"key":"2106_CR25","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.3390\/cancers12123863","volume":"12","author":"F Fico","year":"2020","unstructured":"Fico F, Santamaria-Martinez A. The tumor microenvironment as a driving force of breast cancer stem cell plasticity. Cancers. 2020;12:3863.","journal-title":"Cancers"},{"issue":"2","key":"2106_CR26","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1158\/0008-5472.CAN-10-0538","volume":"71","author":"S Liu","year":"2011","unstructured":"Liu S, Ginestier C, Ou SJ, Clouthier SG, Patel SH, Monville F, et al. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res. 2011;71(2):614\u201324.","journal-title":"Cancer Res"},{"issue":"7162","key":"2106_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature06188","volume":"449","author":"AE Karnoub","year":"2007","unstructured":"Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007;449(7162):557\u201363.","journal-title":"Nature"},{"key":"2106_CR28","doi-asserted-by":"publisher","first-page":"6209","DOI":"10.3390\/cancers13246209","volume":"13","author":"L He","year":"2021","unstructured":"He L, Wick N, Germans SK, Peng Y. The role of breast cancer stem cells in chemoresistance and metastasis in triple-negative breast cancer. Cancers. 2021;13:6209.","journal-title":"Cancers"},{"key":"2106_CR29","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.3390\/cancers12123765","volume":"12","author":"XL Zhang","year":"2020","unstructured":"Zhang XL, Powell K, Li L. Breast cancer stem cells: biomarkers, identification and isolation methods, regulating mechanisms, cellular origin, and beyond. Cancers. 2020;12:3765.","journal-title":"Cancers"},{"key":"2106_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10549-009-0524-9","volume":"118","author":"JC Lawson","year":"2009","unstructured":"Lawson JC, Blatch GL, Edkins AL. Cancer stem cells in breast cancer and metastasis. Breast Cancer Res Treat. 2009;118:241\u201354.","journal-title":"Breast Cancer Res Treat"}],"updated-by":[{"DOI":"10.1007\/s12149-026-02188-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000}}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02106-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-025-02106-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02106-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:53:24Z","timestamp":1773402804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-025-02106-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,5]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2106"],"URL":"https:\/\/doi.org\/10.1007\/s12149-025-02106-8","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,5]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12149-026-02188-y","URL":"https:\/\/doi.org\/10.1007\/s12149-026-02188-y","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no relevant financial or non-financial interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective single-center study adhered to the principles of the Declaration of Helsinki and was approved by the Institutional Review Board and Ethical Committee of Kyoto University Graduate School and Faculty of Medicine (Approval number, R3403). The requirement for informed consent was waived because of the retrospective nature of the study and the use of anonymous clinical data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}